Antenatal corticosteroids are medications given to pregnant women at risk of preterm birth to accelerate fetal lung maturation and reduce neonatal complications. They are most effective when administered between 24 and 34 weeks of gestation and have been shown to significantly decrease the incidence of respiratory distress syndrome and other morbidities in preterm infants.